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Abstract—Good blood glucose control is important to people
with type 1 diabetes to prevent diabetes-related complications.
Too much blood glucose (hyperglycaemia) causes long-term
micro-vascular complications, while a severe drop in blood glu-
cose (hypoglycaemia) can cause life-threatening coma. Finding
the right balance between quantity and type of food intake,
physical activity levels and insulin dosage, is a daily challenge.
Increased physical activity levels often cause changes in blood
glucose due to increased glucose uptake into tissues such as
muscle. To date we have limited knowledge about the minute
by minute effects of exercise on blood glucose levels, in part due
to the difﬁculty in measuring glucose and physical activity levels
continuously, in a free-living environment. By using a light and
user-friendly armband we can record physical activity energy
expenditure on a minute-by-minute basis. Simultaneously, by
using a continuous glucose monitoring system we can record
glucose concentrations. In this paper, Gaussian Processes are
used to model the glucose excursions in response to physical
activity data, to study its effect on glycaemic control.
I. INTRODUCTION
Maintaining normoglycaemia is a daily challenge for peo-
ple with type 1 diabetes. Timely administration of insulin and
a healthy diet are vital in keeping blood glucose within the
physiologically acceptable range of 4−7mmol/l. Extensive
research has been going on in the last thirty years in
modelling the glucose-insulin system [1]. Most of the models
proposed are based on either the Bergman’s minimal model
[2] or Sorensen’s physiological model [3]. These models of-
fer a qualitative prediction tool for blood glucose, in response
to exogenous insulin and carbohydrate intake. It was only
recently that [4] and [5] extended Bergman’s and Sorensen’s
model respectively to account for the effect of physical
activity. Exercise has major effects on blood glucose, mainly
due to the increase of glucose uptake in target peripheral
tissues such as muscle. In both cases this was modelled by a
single parameter PV 0max
2 , which represents the percentage
of the maximal oxygen consumption (V 0max
2 ). Both models
are physiologically based and can explain qualitatively what
happens during varying levels of physical activity. However,
they are not data-true models and hence cannot fully explain
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the erratic changes in blood glucose which occur normally
in people with type 1 diabetes.
Rollins et al. [6] and Vyas et al. [7] were the ﬁrst to
model free-living physical activity data from the armband
[8] and relate it to blood glucose. In both cases the data was
obtained from a single type 2 diabetic wearing the armband
and the continuous glucose monitoring system (CGMS) for
25 days. They used Wiener models and statistical machine
learning algorithms respectively to identify data-true models
which explain the variation in blood glucose levels, given
the physiological signals measured by the armband.
In this paper, Gaussian Processes are used to obtain data-
true models for data coming from type 1 diabetic people
wearing both the armband and the CMGS at the same time.
Being completely insulin deﬁcient, type 1 diabetics exhibit a
more pronounced excursion from the normoglycaemic range
compared to type 2. This makes the modelling process even
more challenging.
II. METHODS AND DATA ACQUISITION
In this section, after brieﬂy presenting the study protocol,
the two main data acquisition devices used in the study are
discussed.
A. Study Protocol
This study was approved by the local ethics committee
LREC: 07/H0502/134.So far a total of 18 people (9 females)
have been recruited in this ongoing study. Table I shows
the characteristic data for this cohort, displayed as mean
± standard deviation. After consenting to the study, several
clinical baseline tests are performed to establish individual
physiological parameters. These have been deemed to be
beyond the scope of this paper discussion and hence omitted.
Each participant was then given a SenseWear
R   Pro 2 arm-
band [8] and the Guardian
R   CGMS [9]. These were worn
for approximately two weeks (the glucose sensor needs to be
replaced every three days). At the same time the participant
was asked to keep a detailed food and insulin diary. This
data collection is repeated again after six months to study
seasonal variations in glycaemic control.
B. SenseWear
R   armband
The armband monitors physical activity using ﬁve different
sensors:
1) Transversal acceleration (measure of movement)
2) Longitudinal acceleration (measure of movement)
3) Heat ﬂux (average heat dissipated or absorbed by the
arm)
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PARTICIPANT’S BASELINE CHARACTERISTICS
Characteristic Value
n=18, 9 Females
Age 36.9±11.6 years
Years with diabetes 16.3±10.9 years
Weight 73±14.4 kg
BMI 25.4±5.6 kg/m2
HbA1c 8.2±1.6 %
4) Galvanic skin response (electrical conductivity be-
tween two points on the arm)
5) Skin and near-body temperature
The sensors are sampled at 32Hz and an average or MAD
(mean of absolute differences) value is stored every minute.
These physiological signals are then combined together using
a proprietary algorithm to estimate the physical activity
energy expenditure.
C. Medtronic Guardian
R   Real-Time Continuous Glucose
Monitoring System
To understand the minute-by-minute relationship between
exercise and blood glucose, the latter needs to be contin-
uously monitored. The Guardian
R   Real-Time Continuous
Glucose Monitoring System (CGMS) by Medtronic (Min-
iMed Inc., CA) is one of the most advanced glucose monitors
currently on the market. It uses a needle-type glucose sensor
which is inserted subcutaneously and measures interstitial
glucose. From this data, blood glucose can be estimated.
To avoid measurement noise from causing sudden changes
in the read-out, the signal is passed through a rate-limiting
ﬁlter. Subsequently, the blood glucose estimate is updated
every 5 mins. Note that the device needs to be calibrated
against a standard ﬁnger-prick measurement every 12 hours.
III. MODELLING FREE-LIVING DATA
Physiologically-based compartmental models use ﬁrst or-
der differential equations to describe glucose dynamics.
Although they can predict qualitatively the overall effect on
blood glucose, they are unable to ﬁt free-living data. Assum-
ing that our prior knowledge is limited, Gaussian Processes
[10] will be used to identify data-true black box models.
Before doing so, the modelling of insulin and carbohydrate
intake is brieﬂy discussed.
A. Modelling Insulin
Type I diabetics are completely insulin deﬁcient, hence all
of the circulating insulin is provided exogenously through
subcutaneous injections. Several insulin ﬂow models have
been proposed in the literature [11]. The pharmacokinetic
model recently proposed by Tarin et al. [12] was employed
here since it is a generic model and covers most of the
insulin preparations currently available. This model uses
three coupled partial differential equations which describe
the time-evolution of insulin in both its hexameric and
dimeric form. For further details about this generic model,
the reader is directed to Tarin et al. [12].
B. Modelling Food Intake
The digestive system is very complex and only few models
have been proposed in the literature. Here we use one of the
simplest, yet most popular model, proposed by Lehmann et
al. [13]. The amount of glucose entering the bloodstream via
the guts is modelled as:
˙ Ggut(t) = Gempt(t) − kabsGgut(t) (1)
Ra(t) = kabsGgut(t) (2)
Where
Ggut(t) is the amount of glucose in the gut [mmol]
Gempt(t) is the rate of gastric emptying [mmol hr−1]
kabs is the rate constant for gut absorption of glucose [hr−1]
Ra(t) is the rate of glucose appearance in the bloodstream
[mmol hr−1]
C. Gaussian Processes
Gaussian Processes (GPs) is a relatively new data mod-
elling technique popularised within the machine learning
community by Rasmussen and Williams [10]. It returns a
non-parametric probabilistic model. A GP is deﬁned as an
inﬁnite ensemble of random variables, any ﬁnite number of
which have a joint normal distribution. It is fully charac-
terised by its mean and covariance function [10]:
f(x) ∼ GP(m(x),k(x,x’)) (3)
m(x) = E[f(x)] (4)
k(x,x’) = E[(f(x) − m(x))(f(x’) − m(x’))] (5)
Where
x is a d-dimensional input space
f(x) is the process we want to model
m(x) is the mean function
k(x,x’) is the covariance function
In GPs we speciﬁcally model the correlations between
the input space. This is very important when dealing with
highly correlated inputs (as is the case here). By quantifying
the similarity between all of the training inputs and the
testing input, a value for the function output is inferred
within a Bayesian framework. The prior in this case is placed
on the function itself. This is very different from other
Bayesian techniques, where the function class is usually
chosen beforehand and the prior is put on its parameters.
These are then chosen to ﬁt the data.
Thus, in GPs, the mean and covariance functions convey
all of our prior knowledge about the process. Without loss
of generality the mean function is usually taken to be zero.
However, in our application a more informed approximation
would be the blood glucose level corresponding to the
individual’s HbA1c (a clinical measure of long-term average
for blood glucose). The covariance function (the similarity
metric) is the most important design parameter as it con-
veys information about the system such as stationarity and
smoothness. One of the most popular stationary covariance
function is the squared exponential:
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2
f exp(−
1
2
(x − x’)
TL(x − x’)) (6)
Where
σ2
f is the function variance
L = diag(l)−2 is the length-scale matrix
Note how the length-scale l dictates how ‘far’ apart each
scalar input x needs to be so as to be deemed correlated.
Together with σ2
f, these form the hyperparameters of a
GP model. These are typically estimated from the data by
minimising the marginal log-likelihood. As discussed in [10],
the length-scale l can be used for Automatic Relevance
Detection (ARD). An input with a very large l will have no
effect whatsoever on the inferred output. Hence, that input
can be considered to be insigniﬁcant. Using this technique,
the most important regressors can be chosen.
IV. RESULTS AND DISCUSSIONS
As an example of a subject-speciﬁc model, data collected
from a participant is presented in this section. The training
data consisted of 6 days, while the validation set consisted
of approximately 3 days.
A. Choosing the regressors
Although ARD can be used to choose the most important
regressors, we still need to decide which ones to start with.
The more regressors in the input space, the more complex
the marginal log-likelihood function becomes and the more
local minima it will have. Also, the regressors that we choose
must be easily understood by clinicians if they are going to
use such models to help treat their patients. Glucose (g),
carbohydrate intake (cho) and insulin (i) are the obvious
regressors. But what about the physical activity parameters?
Transversal and longitudinal acceleration data is difﬁcult
to interpret. However, METs (Metabolic EquivalenT) in
(kcal/kg/hr), a parameter that can be derived from such
data (and other variables measured by the armband), is
clinically well known and understood. It is a multiple of
the resting metabolic rate, that is, the amount of calories
that the body ‘burns’ to keep itself functioning. Heat ﬂux
(hf) in (W/m2) and skin temperature (st) in (◦C) are two
other parameters which are easily understood by clinicians.
Galvanic skin response (µSiemens/m), on the other hand,
was left out because it is difﬁcult to interpret by a diabetolo-
gist and from the data collected it was found to have a very
small variance. Hence, it is not a persistently exciting input
and thus is not suited for model identiﬁcation purposes.
B. Results
Following from the previous discussion, the input space
will now look like this:
[g(k − 1)...g(k − n),cho(k − 1)...cho(k − n),
i(k − 1)...i(k − n),hf(k − 1)...hf(k − n),
st(k − 1)...st(k − n),met(k − 1)...met(k − n)] (7)
Thus, the next step is to choose a value for n, the number
of lagged variables. Intuitively, lags of n = 6 for g, i and
cho, n = 24 for hf and st, and lags between 12 and 48 for
met were considered. Since the sample time is 5mins, these
correspond to lags of 30mins, 2hours and 1hour to 4hours
respectively. These reﬂect the range of time constants for
each variable which were veriﬁed by simulations. People
with type 1 diabetes tend to suffer from hypoglycaemic
events well after they have engaged themselves in strenuous
exercise. This is indeed reﬂected by the range of regressors
chosen for MET which is our main metric for physical
activity.
The squared exponential covariance function deﬁned in 6
was chosen for our model. Measurement noise was modelled
using a covariance function of the type knoise(x,x’) = σ2
nI.
Where σ2
n is the noise variance, which is assumed to be
constant throughout the whole process. Hence, the complete
stationary covariance function is:
k(x,x’) = kse(x,x’) + knoise(x,x’) (8)
The marginal log-likelihood was then minimised and after
using ARD, the model shown in Table II was identiﬁed.
Note that all the input signals (apart from glucose, the output
variable), were normalised to be between [+1,−1].
TABLE II
IDENTIFIED MODEL
Regressor Length-Scale Regressor Length-Scale
g(k − 1) 4.0393 g(k − 2) 5.5136
cho(k − 1) 0.6528 cho(k − 6) 0.2285
i(k − 2) 0.5353 i(k − 3) 0.4737
hf(k − 4) 0.7004 st(k − 1) 0.4228
st(k − 3) 0.2893 st(k − 13) 0.7160
met(k − 42) 0.4280 - -
Hyperparameter Value Hyperparameter Value
σ2
f 2.3924 σ2
n 0.1050
By iteratively feeding back the posterior mean of the
output, 5 (25mins), 12 (1hour) and 48 (4hours) -step ahead
predictions on the validation set were performed. These are
depicted in Figure 1 together with the model-predictedoutput
(that is, inﬁnite-step ahead prediction).
C. Discussions
The results obtained suggest that the identiﬁed model
can predict glucose in the long-term reasonably well. For
the model-predicted output it is interesting to note that
although the predicted value was consistently higher than
the measured one, the rate of change is quite similar. That
is, the model was able to track a decrease/increase in blood
glucose. This suggests that the assumption of stationarity
is not correct. The mean of our system is changing over
time. Note that HbA1c is an average over 120 days, hence
assuming this average for a three day validation set is only
a crude assumption.
There are various other challenges faced in this modelling
problem. Carbohydrate intake and insulin models are merely
look-up tables. They do not differentiate between subjects.
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Carbohydrate and insulin absorption vary considerably be-
tween people. Also, the assumption that only carbohydrates
affect blood sugar is not correct. Fat and protein in food
trigger processes (e.g gluconeogenesis) by which glucose
is synthesised and supplied to the bloodstream when it is
needed. On the other hand insulin absorption depends on
various parameters such as the dose, site of application and
exercise (which tends to increase the diffusion rate). This in-
formation is excluded from the model, which leaves glucose
and physical activity as the only measurable variables.
As with any other sensing technology they both suffer
from measurement noise. In particular, blood glucose which
is estimated indirectly from interstitial glucose. Its accuracy
is very dependent on the frequency and quality of the
calibrations (at least every 12 hours). Calibrations need to be
performed when glucose is the most stable, usually before
going to bed, early morning or just before a meal. These
calibrations are performed against standard glucose meters,
which have an absolute error themselves. As regards the
armband, full details of its validation can be found in [8].
Finally, volunteers were normally monitored for up to 12
days (four glucose sensors). Although it would be very useful
to prolong this, it is very difﬁcult in practice. Even though
the devices used are reasonably small and light, participants
do not feel comfortable wearing them for longer. Also, the
glucose sensor needs to be replaced every three days (for
health and safety reasons). Hence, effectively we are only
getting three days of continuous data, because it is very rare
that people wear them back-to-back. Considering the large
lag between exercise and its effect on blood glucose, this
poses another challenge on the modelling problem.
V. CONCLUSIONS AND FUTURE WORK
A. Conclusions
We have shown that Gaussian Processes may provide a
good starting point for modelling free-living physical activity
data. The importance of these subject-speciﬁc models is to
be able to understand the lag involved between a person
performing daily physical activity and its effect on blood
glucose. This information can be related back to an indi-
vidual’s glycaemic control. Speciﬁcally, how is the persons
lifestyle helping them (or not) in maintaining glucose within
a narrow band, both in the short-term and longer-term.
B. Future Work
We are still in the process of collecting more data from
our volunteers. Having obtained data from different people
who engage themselves in varying levels of physical activity,
we will compare these person-speciﬁc models and look for
similarities and major differences. A longer-term objective is
to identify a single model structure in which parameters are
related to different lifestyles. This will enable us to study the
beneﬁt, in terms of glycaemic regulation, of changing ones
lifestyle.
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